In this panel we get perspectives from the the strategic, the venture capitalist and the product innovation developer on the future of medtech. Where are things headed? What are the strategics looking for from innovators? What should entrepreneurs be thinking about when they approach venture capital funds? Where are the next opportunities in medtech?
Panelists include:
- Noam Krantz, Vice President, Venture Investments, Medical Devices, Johnson & Johson Development Corp
- Greg Madden, Partner, SV Health Investors
- Michael Pereira, President & COO, Ximedica
The moderator is Lisa Carmel, Vice President of Business Development at Ximedica.